公开(公告)号：US20050043330A1

公开(公告)日：2005-02-24

申请号：US10928784

申请日：2004-08-26

Applicant: Michelle Browner ,  David Clark ,  Timothy Cushing ,  Xiaolin Hao ,  Ronald Hawley ,  Xiao He ,  Juan Jaen ,  Sharada Labadie ,  Marie-Louise Smith ,  Francisco Talamas ,  Nigel Walker ,  Marc Labelle

Inventor： Michelle Browner ,  David Clark ,  Timothy Cushing ,  Xiaolin Hao ,  Ronald Hawley ,  Xiao He ,  Juan Jaen ,  Sharada Labadie ,  Marie-Louise Smith ,  Francisco Talamas ,  Nigel Walker ,  Marc Labelle

IPC: A61K31/4709 ,  A61K31/4745 ,  A61K31/5377 ,  A61P3/10 ,  A61P17/06 ,  A61P19/02 ,  A61P29/00 ,  A61P31/04 ,  A61P35/00 ,  A61P43/00 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04 ,  C07D405/14 ,  C07D413/14 ,  C07D417/04 ,  C07D471/04 ,  C12N15/25 ,  C12N15/28 ,  A61K31/519 ,  A61K31/517 ,  C07D487/02 ,  C07D43/02

CPC classification number: C07D401/04 ,  C07D401/14 ,  C07D403/04 ,  C07D405/14 ,  C07D417/04 ,  C07D471/04

Abstract: Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain fused carbocyclic or heterocyclic rings.